Literature DB >> 20065880

Effects of pentoxifylline on inflammation and lung dysfunction in ventilated septic animals.

Itamar Souza Oliveira-Júnior1, Itamar Souza Oliveira, Wagner Rogério Souza Oliveira, Samia Santos Cavassani, Milena Karina Coló Brunialti, Reinaldo Salomao.   

Abstract

Acute respiratory distress syndrome secondary to sepsis is associated with high morbidity and mortality. The purpose of this study was to characterize the effects of ventilatory strategy and the modulating activity of pentoxifylline in a sepsis-induced lung dysfunction model. Male Wistar rats were randomly divided into six groups, undergoing two different ventilatory strategies. Rats received live Escherichia coli or saline intraperitoneally. After 6 hours, the septic animals were treated with either pentoxifylline (25 mg/kg for 20 minutes) or normal saline infusion and ventilated with low tidal volume (6 mL/kg; septic animals with E. coli intraperitoneal [IP] infusion, PTX-treated and ventilated with low tidal volume and septic animals with E. coli IP infusion and ventilated with low tidal volume, respectively) or high tidal volume (12 mL/kg; septic animals with E. coli IP infusion, PTX-treated and ventilated with high tidal volume and septic animals with E. coli IP infusion and ventilated with high tidal volume, respectively) for 3 hours. The control animals received normal saline infusion and, after 6 hours, were ventilated with low or high tidal volume (control animals with saline infusion and ventilated with low tidal volume and control animals with saline infusion and ventilated with high tidal volume, respectively). Lung dysfunctions were assessed by wet-to-dry lung ratios, total cell count, total protein, malondialdehyde, and tumor necrosis factor-alpha concentrations in bronchoalveolar lavage (BAL). Septic animals with E. coli IP infusion and ventilated with high tidal volume presented increased wet-to-dry lung ratios, total cell count, total protein, and malondialdehyde in BAL compared with the septic animals ventilated with low tidal volume. Septic animals treated with pentoxifylline presented higher arterial oxygenation and lower cellular influx, protein leakage, malondialdehyde concentration, and tumor necrosis factor-alpha levels in BAL compared with septic animals undergoing the same ventilatory support strategies (septic animals with E. coli IP infusion and ventilated with low tidal volume and septic animals with E. coli IP infusion and ventilated with high tidal volume). Ventilatory strategy modulated the inflammatory response and pulmonary alterations in a sepsis-induced acute lung injury model, and these effects are improved by pentoxifylline.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065880     DOI: 10.1097/TA.0b013e3181a5f4b5

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  4 in total

1.  Pentoxifylline Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats: Possibly via Inhibiting TLR 4/NF-κB Signaling Pathway.

Authors:  Da-Yong Xia; Hua-Sheng Zhang; Ling-Yun Wu; Xiang-Sheng Zhang; Meng-Liang Zhou; Chun-Hua Hang
Journal:  Neurochem Res       Date:  2016-12-08       Impact factor: 3.996

2.  Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Rama Malaviya; LeRoy Hall; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

Review 3.  Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.

Authors:  L J Mark Cross; Michael A Matthay
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

4.  Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice.

Authors:  Chunlai Feng; Ming Zhang; Sujuan Zhang; Jun Zhang; Chong Li; Jun Zhou
Journal:  BMC Pulm Med       Date:  2021-01-19       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.